Outcomes of patients in South Yorkshire with advanced non-small-cell lung cancer treated with second-line atezolizumab following induction with chemotherapy. (January 2020) - Ryan, A.; Bates, E.; Danson, S.; Das, T.; Fisher, P.; Hatton, M.; Lee, C.; Young, R.; Taylor, F.; Marshall, R.